drugset / Trial / NCT00006386

Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme

NCT00006386

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of radiation therapy followed by carmustine in treating patients who have supratentorial glioblastoma multiforme.

Timeline

Start
2001-03
Primary completion
2004-11
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject carmustine Small molecule 80 mg/m2 Intravenous